|
Market Closed -
Oslo Bors
10:45:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 300.00 NOK | +6.76% |
|
+6.76% | +15.83% |
| 10-23 | Medistim ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 10-23 | Medistim ASA, Q3 2026 Earnings Call, Oct 23, 2026 |
Company Valuation: Medistim ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,693 | 4,216 | 3,912 | 2,738 | 4,735 | 5,488 | - | - |
| Change | - | -37.01% | -7.22% | -30.01% | 72.95% | 15.89% | - | - |
| Enterprise Value (EV) 1 | 6,581 | 4,216 | 3,866 | 2,584 | 4,561 | 5,353 | 5,341 | 5,320 |
| Change | - | -35.93% | -8.31% | -33.16% | 76.51% | 17.37% | -0.21% | -0.4% |
| P/E | 73.8x | 37x | 37.7x | 26.4x | 29.7x | 29.4x | 26.9x | 23.5x |
| PBR | 21.9x | - | - | - | 10.1x | 10.8x | 10.1x | 9.23x |
| PEG | - | 1.5x | -4.13x | - | 0.6x | 1.7x | 2.89x | 1.6x |
| Capitalization / Revenue | 15.7x | 8.57x | 7.43x | 4.87x | 6.77x | 6.68x | 6.16x | 5.66x |
| EV / Revenue | 15.4x | 8.57x | 7.34x | 4.59x | 6.52x | 6.51x | 5.99x | 5.49x |
| EV / EBITDA | 47.1x | 25.6x | 24.9x | 16.6x | 20.6x | 19.8x | 18.2x | 15.9x |
| EV / EBIT | 56.6x | 29.8x | 29.4x | 19.7x | 23.2x | 22x | 19.7x | 17.2x |
| EV / FCF | 56.4x | - | 46.3x | 22.1x | 29.3x | 50x | 32.7x | 27.6x |
| FCF Yield | 1.77% | - | 2.16% | 4.52% | 3.41% | 2% | 3.06% | 3.62% |
| Dividend per Share 2 | 3.75 | - | 4.5 | 6 | 8 | 10 | 9.955 | 10.9 |
| Rate of return | 1.02% | - | 2.1% | 4.01% | 3.09% | 3.33% | 3.32% | 3.63% |
| EPS 2 | 4.98 | 6.24 | 5.67 | 5.67 | 8.71 | 10.2 | 11.15 | 12.75 |
| Distribution rate | 75.3% | - | 79.4% | 106% | 91.8% | 98% | 89.3% | 85.5% |
| Net sales 1 | 427.3 | 491.9 | 526.4 | 562.6 | 699.8 | 822 | 891 | 969 |
| EBITDA 1 | 139.7 | 164.5 | 155.1 | 155.6 | 221 | 270 | 293 | 334 |
| EBIT 1 | 116.3 | 141.3 | 131.4 | 131.1 | 196.2 | 243 | 270.5 | 309 |
| Net income 1 | 90.9 | 114 | 103.8 | 103.8 | 159.2 | 187 | 209 | 237.5 |
| Net Debt 1 | -112.4 | - | -46.1 | -154.2 | -174.6 | -135 | -146.5 | -168 |
| Reference price 2 | 367.50 | 231.00 | 214.00 | 149.50 | 259.00 | 300.00 | 300.00 | 300.00 |
| Nbr of stocks (in thousands) | 18,213 | 18,252 | 18,279 | 18,314 | 18,283 | 18,293 | - | - |
| Announcement Date | 2/25/22 | 3/1/23 | 2/29/24 | 2/28/25 | 2/27/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.41x | 6.51x | 19.83x | 3.33% | 588M | |
| 34.53x | 5.85x | 22.47x | 0.28% | 249B | |
| 36.99x | 6.96x | 21.81x | 0.63% | 162B | |
| 51.68x | 12.65x | 27.12x | -.--% | 157B | |
| 17.34x | 3.44x | 11.18x | -.--% | 66.22B | |
| 49.46x | 12.26x | 27.02x | -.--% | 52.3B | |
| 20.5x | 2.46x | 12.41x | 2.46% | 52.18B | |
| 35.31x | 7.06x | 22.39x | -.--% | 51.34B | |
| 33.72x | 6.68x | 22.73x | 0.59% | 48.79B | |
| 79.42x | 7.56x | 22.95x | -.--% | 44.57B | |
| Average | 38.84x | 7.14x | 20.99x | 0.73% | 88.41B | |
| Weighted average by Cap. | 39.05x | 7.46x | 22.04x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEDI Stock
- Valuation Medistim ASA
Select your edition
All financial news and data tailored to specific country editions
